GSK3B and esophageal squamous cell carcinoma: Consistent with previous studies by our group and others (reviewed in Refs.18–21,23), inhibition of GSK3β attenuated tumor cell survival and proliferation and induced apoptosis in ESCC cells and in xenograft tumors.